日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinoma.

耗竭的 TIL 中的肿瘤反应性 TCR 揭示了肾细胞癌中癌症类型特异性的免疫图谱。

Komahashi Mitsuru, Horaguchi Shun, Tsuji Kayoko, Hoshino Daisuke, Kishida Takeshi, Usui Kimitsugu, Nakaigawa Noboru, Sato Shinya, Hamana Hiroshi, Kishi Hiroyuki, Wei Feifei, Mano Yasunobu, Kouro Taku, Uehara Shuichiro, Sasada Tetsuro

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer

胃癌患者网膜乳斑中免疫细胞的特征及临床意义

Mano, Yasunobu; Igarashi, Yuka; Komori, Keisuke; Hashimoto, Itaru; Watanabe, Hayato; Takahashi, Kosuke; Kano, Kazuki; Fujikawa, Hirohito; Yamada, Takanobu; Himuro, Hidetomo; Kouro, Taku; Wei, Feifei; Tsuji, Kayoko; Horaguchi, Shun; Komahashi, Mitsuru; Oshima, Takashi; Sasada, Tetsuro

Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation

增强基于质谱的肿瘤免疫肽鉴定:利用HLA结合亲和力、脂肪族指数和保留时间偏差的机器学习过滤器

Wei, Feifei; Kouro, Taku; Nakamura, Yuko; Ueda, Hiroki; Iiizumi, Susumu; Hasegawa, Kyoko; Asahina, Yuki; Kishida, Takeshi; Morinaga, Soichiro; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Nakamura, Norihiro; Kawamura, Takeshi; Sasada, Tetsuro

Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures

基于循环细胞因子特征的机器学习在非小细胞肺癌免疫治疗结果预测中的应用

Wei, Feifei; Azuma, Koichi; Nakahara, Yoshiro; Saito, Haruhiro; Matsuo, Norikazu; Tagami, Tomoyuki; Kouro, Taku; Igarashi, Yuka; Tokito, Takaaki; Kato, Terufumi; Kondo, Tetsuro; Murakami, Shuji; Usui, Ryo; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Murotani, Kenta; Ban, Tatsuma; Tamura, Tomohiko; Miyagi, Yohei; Sasada, Tetsuro

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

免疫检查点抑制剂治疗的非小细胞肺癌患者血浆中可溶性PD-1和PD-L1的临床作用

Himuro Hidetomo, Nakahara Yoshiro, Igarashi Yuka, Kouro Taku, Higashijima Naoko, Matsuo Norikazu, Murakami Shuji, Wei Feifei, Horaguchi Shun, Tsuji Kayoko, Mano Yasunobu, Saito Haruhiro, Azuma Koichi, Sasada Tetsuro

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

在接受免疫检查点抑制剂治疗的非小细胞肺癌患者中,循环中的IL-6而非其循环信号成分sIL-6R和sgp130具有临床意义。

Nakahara, Yoshiro; Kouro, Taku; Motoyama, Satoru; Miura, Masatomo; Fujita, Kazuma; Igarashi, Yuka; Higashijima, Naoko; Matsuo, Norikazu; Himuro, Hidetomo; Wei, Feifei; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Komahashi, Mitsuru; Saito, Haruhiro; Azuma, Koichi; Sasada, Tetsuro